Timing note: Intel is scheduled to report after the U.S. market close today, Thursday, July 23, 2026—not tomorrow. The associated 2026Q2 earnings call should follow the release.
Intel enters Q2 with a strong operating narrative but a demanding set of proof points. The company’s Q1 beat was driven by better-than-expected available supply, pricing, mix, and the sale of previously reserved inventory. For Q2, investors will focus less on whether Intel clears its formal guide and more on whether it can demonstrate that:
The setup is therefore more about the quality and durability of the outlook than the headline Q2 result.
Intel guided for:
| Q2 2026 guidance | Midpoint / outlook |
|---|---|
| Revenue | $13.8B–$14.8B |
| Revenue midpoint | $14.3B |
| Non-GAAP gross margin | 39.0% |
| GAAP gross margin | 37.5% |
| Non-GAAP EPS | $0.20 |
| GAAP EPS | $0.08 |
At the midpoint, revenue would grow roughly 5% sequentially from Q1’s $13.6B. But the guide also calls for non-GAAP gross margin to fall from 41.0% in Q1 to 39.0% and non-GAAP EPS to decline from $0.29 to $0.20.
That margin step-down was largely telegraphed. Management attributed it to a much larger contribution from early-ramp Intel 18A products, particularly Panther Lake, plus the absence of Q1 inventory-related benefits. Therefore, merely delivering 39% gross margin may not be enough to satisfy investors: the key is whether the company can show that 18A’s near-term dilution is peaking and that yield/cost improvements are arriving on schedule.
The largest positive debate around Intel is its assertion that AI infrastructure is becoming increasingly CPU-intensive as workloads shift from foundational-model training toward inference, agentic AI, orchestration, networking, and control-plane functions.
In Q1:
A Q2 DCAI result consistent with the guide would support the thesis that Intel’s data-center recovery is more than a short-cycle replenishment event. More important, investors will listen for evidence on:
The key risk: Management’s demand commentary has become very bullish. If DCAI is merely in line but the outlook becomes less emphatic, the market could interpret it as evidence that the AI/CPU opportunity is being over-extrapolated.
CCG generated $7.7B in Q1, up only 1% year over year but ahead of Intel’s internal expectations. Management cited resilient demand, improved supply, pricing, and increased AI-PC penetration; AI PCs represented more than 60% of client CPU mix in Q1.
However, Intel also forecast that the full-year PC unit TAM could decline by low double digits, with second-half demand softer than the first half. It said client revenue could remain roughly flat from Q2 through year-end, supported by pricing and customer inventory replenishment even as end-market consumption weakens.
This makes Q2 CCG results somewhat ambiguous:
Investors should not mistake a good CCG revenue number for a clean PC-cycle recovery unless Intel explicitly identifies improving consumption trends.
Intel’s Q1 non-GAAP gross margin of 41.0% was unusually strong relative to its earlier outlook, benefiting from volume, product mix, pricing, better yields, and previously reserved inventory. Q2’s 39.0% guide effectively acknowledges that some of those benefits do not repeat.
The central issue is Intel 18A:
Bull case: Intel matches or exceeds the 39% margin target while signaling that 18A yields, throughput, and product costs are improving faster than expected.
Bear case: Intel delivers revenue but misses on gross margin or offers a cautious second-half margin outlook, suggesting that the manufacturing recovery is costing more—or taking longer—than investors expect.
For this report, a revenue beat paired with weak gross margin would likely be viewed less favorably than a modest revenue result with clear evidence of improving 18A economics.
Intel Foundry is central to the long-term equity story, but it remains financially burdensome today.
In Q1:
Recent developments strengthen the strategic narrative:
The report’s foundry questions are straightforward:
Important distinction: Fortinet is strategically useful validation, but it is not yet the kind of large, leading-edge foundry customer that would fully underwrite Intel’s multiyear manufacturing investment case.
Intel’s operational recovery comes with a large capital requirement.
In Q1:
The Fab 34 transaction added further complexity: Intel repurchased the 49% minority interest in the Ireland venture using approximately $7.7B of cash and $6.5B of new debt. Management characterized the deal as economically attractive, but investors will want confirmation that debt reduction, factory investment, and free-cash-flow goals remain compatible.
Watch for:
The stock has been volatile into earnings. INTC closed at $102.65 on July 22, down roughly 26.5% from June 30, versus a decline of about 13.3% for SOXX over the same interval; it also rebounded about 8.0% from its July 17 close. That pattern suggests some de-risking has occurred, but the recent rebound indicates that investor appetite for a favorable earnings catalyst has returned.
The recent move also means the market is likely balancing two competing views:
A constructive outcome would likely include:
The bear case would be:
Intel has shifted from a survival story to an execution story. Q2 is unlikely to settle the long-term debate, but it can materially affect confidence in three variables: DCAI growth durability, 18A gross-margin progression, and foundry commercialization.
The most important line to watch is not simply Q2 revenue or EPS. It is management’s answer to a broader question:
Can Intel add supply fast enough to capture AI-driven CPU demand while improving, rather than sacrificing, the economics of its manufacturing model?
If the answer is increasingly “yes,” the company’s recovery case strengthens. If revenue growth comes at the expense of margins, cash flow, and still-speculative foundry expectations, the report may reinforce the view that Intel’s turnaround remains early and capital-intensive.